Study of the Consumption of a Food Supplement in a Group of Healthy People
NCT ID: NCT03492086
Last Updated: 2018-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2015-08-31
2015-12-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pharmacokinetic Profile of Rosemary Extract Supplement
NCT05931341
The Effect of Aged Garlic Extract Supplementation on Immune System
NCT01390116
Effects of Garlic Supplements on Drug Metabolism
NCT00122889
Evaluation of Soy-protein Russian Tarragon (Artemisia Dracunculus L.)
NCT02088203
A Sub-Chronic Evaluation of the Safety of Celastrol in Human Subjects
NCT05494112
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rosemary and alkylglycerol capsules
Dietary supplementation with capsules containing rosemary and alkylglycerol
Control capsules
Dietary supplementation with control capsules
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary supplementation with capsules containing rosemary and alkylglycerol
Dietary supplementation with control capsules
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adequate understanding of the study.
* Willingness to complete the entire treatment.
Exclusion Criteria
* Diagnosis of type 2 diabetes mellitus (T2D), hypertension, dyslipidemia or other cardiometabolic disorders
* Impaired cognitive function;
* Diagnosed hepatic, renal, or cardiovascular disease
* Subjects with primary immunodeficiency disorders, consumption of drugs with influence on the immune system, splenectomy.
* Presence of other pathologies like asthma, food allergies, Crohn's, myasthenia gravis, lupus
* Consumption of vitamins, minerals, supplements of antioxidant extracts or protein supplements in the 2 weeks prior to the start of the study
* Subjects treated with drugs affecting the lipid or glycemic profile during the previous 30 days
* Consumption of anticoagulants or antiplatelet agents, cyclosporine, acetylsalicylic acid, antihistamines or sedatives
* Hypersensitivity to rosemary, to its components or other members of the family of lipped plants or to soybean as excipient of the capsules
* Allergy or hypersensitivity to fish
* Habitual smoking or high consumption alcohol
* Pregnant or lactating women
* High-intensity physical exercise.
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IMDEA Food
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillermo Reglero, Proffesor
Role: STUDY_DIRECTOR
IMDEA Food and Institute of Food Science Research (CIAL)
Ana Ramirez de Molina, PhD
Role: PRINCIPAL_INVESTIGATOR
IMDEA Food
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Viviana loria-Kohen
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Al-Darmaki S, Knightshead K, Ishihara Y, Best A, Schenkein HA, Tew JG, Barbour SE. Delineation of the role of platelet-activating factor in the immunoglobulin G2 antibody response. Clin Diagn Lab Immunol. 2004 Jul;11(4):720-8. doi: 10.1128/CDLI.11.4.720-728.2004.
Deniau AL, Mosset P, Pedrono F, Mitre R, Le Bot D, Legrand AB. Multiple beneficial health effects of natural alkylglycerols from shark liver oil. Mar Drugs. 2010 Jul 19;8(7):2175-84. doi: 10.3390/md8072175.
Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hutterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Muhlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017 Feb;36(1):11-48. doi: 10.1016/j.clnu.2016.07.015. Epub 2016 Aug 6.
August DA, Huhmann MB; American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr. 2009 Sep-Oct;33(5):472-500. doi: 10.1177/0148607109341804. No abstract available.
Gonzalez-Vallinas M, Molina S, Vicente G, de la Cueva A, Vargas T, Santoyo S, Garcia-Risco MR, Fornari T, Reglero G, Ramirez de Molina A. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells. Pharmacol Res. 2013 Jun;72:61-8. doi: 10.1016/j.phrs.2013.03.010. Epub 2013 Apr 1.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 Dec;25(4):402-8. doi: 10.1006/meth.2001.1262.
Suchner U, Kuhn KS, Furst P. The scientific basis of immunonutrition. Proc Nutr Soc. 2000 Nov;59(4):553-63. doi: 10.1017/s0029665100000793.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IMD PI0017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.